Gene signatures

Signatures (52) and Custom Report Builder
Title Organism Platform
1 Oncogenic BRAF harboring melanoma cell line response to BRAF inhibition Homo sapiens Homo sapiens
2 PGC1alpha depletion effect on melanoma cell line Homo sapiens Homo sapiens
3 CD133 depletion effect on metastatic melanoma cell line Homo sapiens Homo sapiens
4 Dual roles of RNF2 in melanoma progression [expression] Homo sapiens Homo sapiens
5 Shp2 transcriptome in melanoma Homo sapiens Homo sapiens
6 TGFβ1 treatment of A2058 melanoma cells Homo sapiens Homo sapiens
7 siRNA induced silencing of CITED1 in HT144 human melanoma cells Homo sapiens Homo sapiens
8 Transcriptome data from human malanoma A375 cells stably expressing MAP4K5 shRNA. Homo sapiens Homo sapiens
9 Functional analysis of ABCB5 in melanoma cells Homo sapiens Homo sapiens
10 Analysis of global changes in gene expression induced by human polynucleotide phosphorylase (hPNPaseold-35) Homo sapiens Homo sapiens
11 Synergistic anti-tumor activity by association of MEK and PI3K/mTOR blockade with TRAIL in human melanoma Homo sapiens Homo sapiens
12 Synergistic anti-tumor activity by association of MEK and PI3K/mTOR blockade with TRAIL in human melanoma Homo sapiens Homo sapiens
13 Oncogenic BRAF harboring melanoma cell line response to BRAF inhibition Homo sapiens Homo sapiens
14 SOX9 overexpression in melanoma Homo sapiens Homo sapiens
15 Synergistic anti-tumor activity by association of MEK and PI3K/mTOR blockade with TRAIL in human melanoma Homo sapiens Homo sapiens
16 Molecular changes induced by melanoma cell conditioned medium (MCM) in HUVEC cells. Homo sapiens Homo sapiens
17 Gene expression profile in melanomas from Pdk1-inactivated BrafV600E::Pten-/- mice Mus musculus Mus musculus
18 The role of SOX10 in human melanoma Homo sapiens Homo sapiens
19 The role of SOX10 in human melanoma Homo sapiens Homo sapiens
20 Expression data from Control, Uninfected and BRAF infected cells Homo sapiens Homo sapiens
21 EWI-2 regulates melanoma growth and lung metastasis in a TGF-β1-dependent manner Homo sapiens Homo sapiens
22 Gene expression profiling of enforced HOXA1 expression in melanoma cell line Homo sapiens Homo sapiens
23 Gene expression profiling of enforced HOXA1 expression in melanoma cell line (SkMel30) Homo sapiens Homo sapiens
24 Expression data from mouse B16-F10 cells exposed to hypoxic conditions in vitro. Mus musculus Mus musculus
25 Expression data from mouse B16-F10 cells exposed to hypoxic conditions in vitro. Mus musculus Mus musculus
26 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
27 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
28 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
29 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
30 Gene expression profiles of Wnt-1 overexpressing melanoma Homo sapiens Homo sapiens
31 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
32 Gene expression profiles of Wnt-1 overexpressing melanoma Homo sapiens Homo sapiens
33 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
34 Analysis of A375 and A375 clones that acquired resistance to GSK2118436 after treatment with GSK2118436 (GSK436), GSK1120212 (GSK212), or the combination of GSK2118436 and GSK1120212 for 24 hour Homo sapiens Homo sapiens
35 Expression data from mouse B16-F10 cells exposed to hypoxic conditions in vitro. Mus musculus Mus musculus
36 Expression data from mouse B16-F10 cells exposed to hypoxic conditions in vitro. Mus musculus Mus musculus
37 Role of Apollon in human melanoma resistance to anti-tumor agents that activate the intrinsic or the extrinsic apoptosis pathways Homo sapiens Homo sapiens
38 Inhibitor of NEDD8-activating enzyme MLN4924 effect on melanoma cell line Homo sapiens Homo sapiens
39 Expression data from mouse B16-F10 cells treated with heat shock (HS), Lipofectamine 2000 (LA), and benzyl alcohol (BA) Mus musculus Mus musculus
40 Expression data from mouse B16-F10 cells treated with heat shock (HS), Lipofectamine 2000 (LA), and benzyl alcohol (BA) Mus musculus Mus musculus
41 Inhibitor of NEDD8-activating enzyme MLN4924 effect on melanoma cell line Homo sapiens Homo sapiens
42 Expression data from mouse B16-F10 cells treated with heat shock (HS), Lipofectamine 2000 (LA), and benzyl alcohol (BA) Mus musculus Mus musculus
43 Inhibitor of NEDD8-activating enzyme MLN4924 effect on melanoma cell line Homo sapiens Homo sapiens
44 Inhibitor of NEDD8-activating enzyme MLN4924 effect on melanoma cell line Homo sapiens Homo sapiens
45 Inhibitor of NEDD8-activating enzyme MLN4924 effect on melanoma cell line Homo sapiens Homo sapiens
46 Anti-proliferative effects of continued mitogen activated protein kinase pathway inhibition following acquired resistance to BRAF and/or MEK inhibition in melanoma: Implications for treatment beyond disease progression Homo sapiens Homo sapiens
47 CD133 depletion effect on metastatic melanoma cell line Homo sapiens Homo sapiens
48 KINK-1, a novel small-molecule inhibitor of IKKbeta, enhances susceptibility of melanoma cells to antitumoral treatment Homo sapiens Homo sapiens
49 KINK-1, a novel small-molecule inhibitor of IKKbeta, enhances susceptibility of melanoma cells to antitumoral treatment Homo sapiens Homo sapiens
50 KINK-1, a novel small-molecule inhibitor of IKKbeta, enhances susceptibility of melanoma cells to antitumoral treatment Homo sapiens Homo sapiens
51 Analysis of genes regulated by FoxD3 in B16-F10 mouse melanoma cells Mus musculus Mus musculus
52 Hs 294T Cells Treated with Elesclomol Alone or in Combination with NAC Compared to DMSO Treated Homo sapiens Homo sapiens

PCA

Interactive 3D principal component analysis of gene signatures. You can rotate the visualization and mouse over the data points.

Genes

Hierarchical clustering of genes based on weights from the differential expression method.

Enrichr

Enrichr is a web tool that performs gene set enrichment analysis. To generate the hierarchical clusterings below, GEN3VA enriched each gene signature using Enrichr and then clustered the terms. Use the select button to change Enrichr's background library.

Hierarchical clustering of enriched terms from

L1000CDS2

L1000CDS2 is a web tool that queries the LINCS L1000 dataset to identify small molecules that can reverse or mimic the observed input expression pattern. To generate the hierarchical clustering below, GEN3VA enriched each gene signature using L1000CDS2 to generate a list of perturbations that either mimic (red) and reverse (blue) expression.